These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2095636)

  • 1. [Therapy of urinary tract infections. Clinical experience comparing norfloxacin to other quinolones].
    Fischetti G; Stillitani E; Michetti P; Massa P; Mastroberardino G
    Minerva Urol Nefrol; 1990; 42(4):211-3. PubMed ID: 2095636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
    Obana Y; Nishino T
    Drugs Exp Clin Res; 1989; 15(2):53-8. PubMed ID: 2661182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative evaluation of norfloxacin and cinoxacin in the therapy of complicated infections of the urinary tract].
    Cristiano P; Morelli G; Simioli F; Iovene MR; Della Vittoria Scarpati M; Manguso L
    Minerva Med; 1989 Apr; 80(4):393-5. PubMed ID: 2657499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative therapeutic evaluation of 2 quinolone derivatives, norfloxacin and cinoxacin, in complicated infections of the urinary tract].
    Tizzani A; Casetta G; Piana P
    Minerva Urol Nefrol; 1985; 37(4):489-92. PubMed ID: 3834630
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative clinical study of the antibacterial activity of cinoxacin and norfloxacin in urinary tract infections].
    Pennisi M; Viscusi G; Salanitri G; Cammarata E; Gazzo G
    Minerva Urol Nefrol; 1987; 39(1):51-6. PubMed ID: 3616862
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of urinary infections in gynecology. Comparative study of norfloxacin, oxolinic acid and pipemidic acid carried out on ambulatory patients].
    Capalbi A; Buzzi M; Alessandrini A; Allegra E; Mogini C; Di Salvo G
    Minerva Urol Nefrol; 1987; 39(4):383-9. PubMed ID: 3451376
    [No Abstract]   [Full Text] [Related]  

  • 7. [In vitro comparative activity of norfloxacin in the comparison of pathogenic bacteria of the urinary tract].
    Carlone NA; Cuffini AM; Tullio V; Savoia D; Cavallo GP
    G Batteriol Virol Immunol; 1986; 79(1-6):85-97. PubMed ID: 3479370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative evaluation of cinoxacin, cotrimoxazole and pipemidic acid in recurrent infections of the lower urinary tract in long-term therapy].
    Aimè G; Governa M; Polledro P
    Minerva Urol Nefrol; 1987; 39(2):129-34. PubMed ID: 3498226
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of fluoroquinolones (norfloxacin, enoxacin, ofloxacin) in the therapy of lower urinary tract infections].
    Tizzani A; Casetta G; Cavallini A; Piana P
    Minerva Urol Nefrol; 1990; 42(2):81-4. PubMed ID: 2392745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections.
    Naber KG; Sörgel F; Gutzler F; Bartosik-Wich B
    Infection; 1985; 13(5):219-24. PubMed ID: 2933340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of urinary infections: clinical perspectives.
    Fontana G; Laudi M; Carlone NA; Savoia D
    Chemioterapia; 1987 Feb; 6(1):45-9. PubMed ID: 3549009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibacterial activity of norfloxacin and pipemidic acid in a randomized double-blind study].
    Zerqueni G; Rocca Rossetti S
    Minerva Urol Nefrol; 1984; 36(3):247-51. PubMed ID: 6241966
    [No Abstract]   [Full Text] [Related]  

  • 13. Experiences on the efficacy and safety of nalidixic acid, oxolinic acid, cinoxacin and norfloxacin in the treatment of urinary tract infections (UTI).
    Sabbour MS; El Bokl MA; Osman LM
    Infection; 1984; 12(6):377-80. PubMed ID: 6240470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of 4-quinolones in the treatment of infections.
    Cynamon MH; Wilcox GH
    Compr Ther; 1987 Feb; 13(2):37-43. PubMed ID: 3545658
    [No Abstract]   [Full Text] [Related]  

  • 15. Norfloxacin versus pipemidic acid in complicated urinary tract infections due to susceptible pathogens: a comparative clinical trial.
    Del Favero A; Frongillo RF; Menichetti F; Boldrini F; Guerciolini R; Pauluzzi S
    Chemioterapia; 1986 Apr; 5(2):88-91. PubMed ID: 3518966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Single oral dose of phosphomycin trometamol versus pipemidic acid and norfloxacin in treating uncomplicated low-level urinary tract infections].
    Cortés R; Pascual T; Lou Arnal S; Orozco F; Sunyer L
    Aten Primaria; 1992 Dec; 10(9):1007-12. PubMed ID: 1467416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic prophylaxis of urinary tract infections in diabetic patients].
    Di Mauro M; Leonardi R; La Bella G; Iani P
    Minerva Med; 1990; 81(1-2):69-74. PubMed ID: 2314619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norfloxacin versus nalidixic acid in the treatment of urinary tract infections.
    Karachalios GN; Georgiopoulos AN
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):317-9. PubMed ID: 3623736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infections.
    Hirai K; Ito A; Abe Y; Suzue S; Irikura T; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1981 Jan; 19(1):188-9. PubMed ID: 6454381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical results of the use of pipemidic acid in the common urinary tract infections].
    Martini G; Romano G
    Clin Ter; 1980 Apr; 93(1):25-31. PubMed ID: 7449330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.